Generate a tailored SOP for Dr. Martina Damo. Improve your application with a focused, well-structured draft.
Martina Damo earned her PhD in Bioengineering from the Swiss Federal Institute of Technology in Lausanne (EPFL) in 2016 and subsequently completed a postdoctoral fellowship in Immunobiology at Yale University in 2022. She joined the Faculty of the University of Chicago as an Assistant Professor in October 2023. Damo runs a research laboratory focused on understanding the immune checkpoint receptors expressed by T cells and their contribution to immunological tolerance in physiological settings. Her work also investigates how immunotherapy checkpoint blockade can lead to immune-related adverse events (irAEs) in cancer patients. The primary goal of her research is to identify pathways through which T cell tolerance can be druggable, and to bioengineer targeted therapies that can either induce or prevent tolerance depending on the disease setting. Furthermore, she is developing therapeutic approaches to prevent or limit irAEs in cancer patients.
Department of Philosophy